From DCAT Value Chain Insights (VCI)
Mayne Pharma has appointed Q. Dwight Lewis as vice president of quality for its operations in the United States. Lewis is responsible for managing all quality-related functions to ensure that Mayne Pharma’s US pharmaceutical operations, which range from laboratories to manufacturing lines, continue to comply with global regulatory agency and industry standards.
Before joining Mayne Pharma, Lewis was senior director of quality for Teva Pharmaceuticals, where he managed quality assurance and control functions for solid dose manufacturing. Prior to that, he served as vice president of quality for Irix Pharmaceuticals and as director of quality operations for DSM Pharmaceuticals.
Lewis brings to his new role expertise in new chemical entity development, active pharmaceutical ingredient, and solid dose form manufacturing, generic product development, and contract services. He holds a bachelor’s degree in chemistry from the University of North Carolina at Chapel Hill.
Source: Mayne Pharma
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription